标题
Multiple sclerosis—a quiet revolution
作者
关键词
-
出版物
Nature Reviews Neurology
Volume 11, Issue 3, Pages 134-142
出版商
Springer Nature
发表日期
2015-02-17
DOI
10.1038/nrneurol.2015.14
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event
- (2014) Darin T. Okuda et al. PLoS One
- B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
- (2014) J. N. H. Stern et al. Science Translational Medicine
- Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial
- (2013) Ralf Gold et al. LANCET
- Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis
- (2013) Luca Prosperini et al. Multiple Sclerosis Journal
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
- (2013) Ashley H Beecham et al. NATURE GENETICS
- Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus
- (2013) L. Ottoboni et al. NEUROLOGY
- Mortality in patients with multiple sclerosis
- (2013) A. Scalfari et al. NEUROLOGY
- JC Viremia in Natalizumab-Treated Patients with Multiple Sclerosis
- (2013) Eugene O. Major et al. NEW ENGLAND JOURNAL OF MEDICINE
- A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis
- (2013) Calliope A Dendrou et al. PHARMACOGENOMICS
- Cortical remyelination: A new target for repair therapies in multiple sclerosis
- (2012) Ansi Chang et al. ANNALS OF NEUROLOGY
- Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta
- (2012) Robert A. Bermel et al. ANNALS OF NEUROLOGY
- Benign Multiple Sclerosis: Does it exist?
- (2012) Jorge Correale et al. Current Neurology and Neuroscience Reports
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Low degree of cortical pathology is associated with benign course of multiple sclerosis
- (2012) Massimiliano Calabrese et al. Multiple Sclerosis Journal
- Survival in MS
- (2012) D.S. Goodin et al. NEUROLOGY
- Association of MRI metrics and cognitive impairment in radiologically isolated syndromes
- (2012) M. P. Amato et al. NEUROLOGY
- Humoral-Targeted Immunotherapies in Multiple Sclerosis
- (2012) Sabeen Lulu et al. Neurotherapeutics
- Interferon Beta and Glatiramer Acetate Therapy
- (2012) Corey A. McGraw et al. Neurotherapeutics
- Fingolimod for Multiple Sclerosis
- (2012) Daniel Pelletier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- An RNA Profile Identifies Two Subsets of Multiple Sclerosis Patients Differing in Disease Activity
- (2012) L. Ottoboni et al. Science Translational Medicine
- Immune-mediated disease genetics: the shared basis of pathogenesis
- (2012) Chris Cotsapas et al. TRENDS IN IMMUNOLOGY
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity
- (2011) Xin Chen et al. FEBS LETTERS
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo
- (2011) Yinghui Hu et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Effect of BG-12 on contrast-enhanced lesions in patients with relapsing– remitting multiple sclerosis: subgroup analyses from the phase 2b study
- (2011) Ludwig Kappos et al. Multiple Sclerosis Journal
- Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors
- (2011) Andrew J Solomon et al. Multiple Sclerosis Journal
- A case of multiple sclerosis presenting with inflammatory cortical demyelination
- (2011) B. F. G. Popescu et al. NEUROLOGY
- Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome
- (2011) D. T. Okuda et al. NEUROLOGY
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
- (2010) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- The use of ustekinumab in autoimmune disease
- (2010) Caitriona Ryan et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Humoral autoimmunity in multiple sclerosis
- (2010) Edgar Meinl et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- PML risk and natalizumab: more questions than answers
- (2010) Richard M Ransohoff LANCET NEUROLOGY
- Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
- (2010) Daniel Wynn et al. LANCET NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natalizumab in the treatment of multiple sclerosis
- (2010) Brandon Brown Therapeutics and Clinical Risk Management
- Real-life impact of early interferonβ therapy in relapsing multiple sclerosis
- (2009) M. Trojano et al. ANNALS OF NEUROLOGY
- A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
- (2009) M. Comabella et al. BRAIN
- The relation between inflammation and neurodegeneration in multiple sclerosis brains
- (2009) Josa M. Frischer et al. BRAIN
- Benign or not benign MS: A role for routine neuropsychological assessment?
- (2009) R. H.B. Benedict et al. NEUROLOGY
- Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis
- (2009) E. Portaccio et al. NEUROLOGY
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) G Comi et al. LANCET
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
- (2008) Ludwig Kappos et al. LANCET
- Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
- (2008) Benjamin M Segal et al. LANCET NEUROLOGY
- Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study
- (2008) M Calabrese et al. Multiple Sclerosis Journal
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search